Certara’s D360 to offer access to Thomson Reuters’s Cortellis to integrate internal with external data
ST. LOUIS, MO – January 15, 2013 – Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and Thomson Reuters have signed a partnership agreement. The partnership will focus on providing seamless access to data in Thomson Reuter’s Cortellis™ via Certara’s D360™.
D360 is an integrated solution for query, analysis and visualization of scientific data. It is used by scientists at pharmaceutical and biotech companies to provide unified access to disparate data sources throughout drug discovery and development, greatly improving research productivity. Through this partnership with Thomson Reuters, Certara can provide access to the Cortellis curated data through D360, allowing researchers to query internal and external data simultaneously, comparing an internal development program with public curated data.
Certara is dedicated to improving human health through a broad spectrum of software products and consulting services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara was formed by uniting industry leaders Tripos®, provider of innovative scientific software solutions and services enabling life science researchers to improve the efficiency of molecular discovery; Simcyp™, a research-based company providing predictive pharmacokinetic and pharmacodynamics tools, workshops, and consultancy services; and Pharsight® Corporation, provider of software and scientific consulting services to improve productivity and decision-making in preclinical and clinical drug development. Each Certara family brand has a primary focus on a key phase within the drug discovery and development process; combined, they offer a unique set of capabilities for modeling, analysis, and simulation with scientific informatics that can enable the cross-disciplinary approaches necessary for translational science initiatives.
Diana O’Rourke, 314-951-3310
Director of Marketing